Title: An inquiry into the ImClone cancer-drug story
Subjects: Cetuximab, Corrupt practices, Drugs, ImClone Systems Incorporated, Insider trading in securities, Testing, Drugs, testing, Business enterprises, corrupt practices
Places: United States